Skip to main content

Advertisement

Log in

Diagnostic work-up of contralateral breast cancers has not improved over calendar period

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Women who have been treated for breast cancer are typically followed up with regular mammography and palpation, with the aim of detecting recurrences and contralateral breast cancer (CBC). This study aims to investigate if the diagnostic work-up of breast cancer patients has improved over the last 25 years and resulted in earlier diagnoses of CBC. Two population-based cohorts were used; all CBCs in Sweden 1976–2004 (n: 2932), and all CBCs in Stockholm, Sweden, 1976–2005 (n: 626), both cohorts with a maximum of 3 years between the two cancers. Synchronous CBC was defined as two cancers <3 months apart, the remainder was defined as metachronous CBC. We calculated the odds ratio of being diagnosed synchronously, relative to metachronously, using logistic regression, adjusting for whether the second cancer was detected through clinical work-up or not. The odds of synchronous CBC were significantly increased: 1.27 (95% CI, 1.13–1.42) per 5-year period, compared to metachronous, and was not affected by detection mode, but seemed to be explained by adjuvant therapy. The proportion of CBCs detected by clinical work-up did not increase over the study period, and the mean size of the second tumor remained constant. We found an increase in the proportion of synchronous CBCs compared to metachronous, over calendar period, a change that was not associated with clinical work-up, but with adjuvant therapy. This study gives no indications that any improvement in diagnostic work-up of CBC have occurred over the last 25 years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hungness ES, Safa M, Shaughnessy EA, Aron BS, Gazder PA, Hawkins HH, Lower EE, Seeskin C, Yassin RS, Hasselgren PO (2000) Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. Surgery 128:702–707

    Article  CAS  PubMed  Google Scholar 

  2. Jobsen JJ, van der Palen J, Ong F, Meerwaldt JH (2003) Synchronous, bilateral breast cancer: prognostic value and incidence. Breast 12:83–88

    Article  CAS  PubMed  Google Scholar 

  3. Polednak AP (2003) Bilateral synchronous breast cancer: a population-based study of characteristics, method of detection, and survival. Surgery 133:383–389

    Article  PubMed  Google Scholar 

  4. Yeatman TJ, Lyman GH, Smith SK, Reintgen DS, Cantor AB, Cox CE (1997) Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. Ann Surg Oncol 4:198–202

    Article  CAS  PubMed  Google Scholar 

  5. Adami HO, Bergstrom R, Hansen J (1985) Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study. Cancer 55:643–647

    Article  CAS  PubMed  Google Scholar 

  6. Chen Y, Semenciw R, Kliewer E, Shi Y, Mao Y (2001) Incidence of second primary breast cancer among women with a first primary in Manitoba, Canada. Breast Cancer Res Treat 67:35–40

    Article  CAS  PubMed  Google Scholar 

  7. Hartman M, Czene K, Reilly M, Adolfsson J, Bergh J, Adami HO, Dickman PW, Hall P (2007) Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol 25:4210–4216

    Article  PubMed  Google Scholar 

  8. Robbins GF, Berg JW (1964) Bilateral primary breast cancer; a prospective clinicopathological study. Cancer 17:1501–1527

    Article  CAS  PubMed  Google Scholar 

  9. Swedish Organised Service Screening Evaluation Group (2007) Effect of mammographic service screening on stage at presentation of breast cancers in Sweden. Cancer 109:2205–2212

    Article  Google Scholar 

  10. Olsson S, Andersson I, Karlberg I, Bjurstam N, Frodis E, Hakansson S (2000) Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme. J Med Screen 7:14–18

    Article  CAS  PubMed  Google Scholar 

  11. Hendrick RE, Berns EA (2000) Optimizing techniques in screen-film mammography. Radiol Clin North Am 38:701–718 (viii)

    Article  CAS  PubMed  Google Scholar 

  12. Harlan LC, Clegg LX, Abrams J, Stevens JL, Ballard-Barbash R (2006) Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987–2000. J Clin Oncol 24:872–877

    Article  CAS  PubMed  Google Scholar 

  13. Kemetli L, Rutqvist LE, Jonsson H, Nystrom L, Lenner P, Tornberg S (2009) Temporal trends in the use of adjuvant systemic therapy in breast cancer: a population based study in Sweden 1976–2005. Acta Oncol 48:59–66

    Article  CAS  PubMed  Google Scholar 

  14. Mariotto A, Feuer EJ, Harlan LC, Wun LM, Johnson KA, Abrams J (2002) Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975–1999. J Natl Cancer Inst 94:1626–1634

    CAS  PubMed  Google Scholar 

  15. Vervoort MM, Draisma G, Fracheboud J, van de Poll-Franse LV, de Koning HJ (2004) Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer 91:242–247

    CAS  PubMed  Google Scholar 

  16. Mattsson B, Wallgren A (1984) Completeness of the Swedish cancer register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 23:305–313

    Article  CAS  PubMed  Google Scholar 

  17. Barlow L, Westergren K, Holmberg L, Talback M (2009) The completeness of the Swedish cancer register: a sample survey for year 1998. Acta Oncol 48:27–33

    Article  PubMed  Google Scholar 

  18. Jonsson H, Johansson R, Lenner P (2005) Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer 117:842–847

    Article  CAS  PubMed  Google Scholar 

  19. McKinlay SM (1996) The normal menopause transition: an overview. Maturitas 23:137–145

    Article  CAS  PubMed  Google Scholar 

  20. Schaapveld M, Visser O, Louwman WJ, Willemse PH, de Vries EG, van der Graaf WT, Otter R, Coebergh JW, van Leeuwen FE (2008) The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat 110:189–197

    Article  CAS  PubMed  Google Scholar 

  21. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717

    Article  Google Scholar 

  22. Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225:165–175

    Article  PubMed  Google Scholar 

  23. Titus-Ernstoff L, Tosteson AN, Kasales C, Weiss J, Goodrich M, Hatch EE, Carney PA (2006) Breast cancer risk factors in relation to breast density (United States). Cancer Causes Control 17:1281–1290

    Article  PubMed  Google Scholar 

  24. Robinson A, Speers C, Olivotto I, Chia S (2007) Method of detection of new contralateral primary breast cancer in younger versus older women. Clin Breast Cancer 7:705–709

    Article  PubMed  Google Scholar 

  25. Roubidoux MA, Helvie MA, Lai NE, Paramagul C (1995) Bilateral breast cancer: early detection with mammography. Radiology 196:427–431

    CAS  PubMed  Google Scholar 

  26. Berg WA (2009) Tailored supplemental screening for breast cancer: what now and what next? AJR Am J Roentgenol 192:390–399

    Article  PubMed  Google Scholar 

  27. Hou MF, Chuang HY, Ou-Yang F, Wang CY, Huang CL, Fan HM, Chuang CH, Wang JY, Hsieh JS, Liu GC, Huang TJ (2002) Comparison of breast mammography, sonography and physical examination for screening women at high risk of breast cancer in Taiwan. Ultrasound Med Biol 28:415–420

    Article  PubMed  Google Scholar 

  28. Lehman CD, Gatsonis C, Kuhl CK, Hendrick RE, Pisano ED, Hanna L, Peacock S, Smazal SF, Maki DD, Julian TB, DePeri ER, Bluemke DA, Schnall MD (2007) MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356:1295–1303

    Article  CAS  PubMed  Google Scholar 

  29. Samant RS, Olivotto IA, Jackson JS, Mates D (2001) Diagnosis of metachronous contralateral breast cancer. Breast J 7:405–410

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was financed by the Swedish Research Council Grant no: 521-2008-2728. Kamila Czene was financed by the Swedish Cancer Society grant no: 5128-B07-01PAF. We would also like to acknowledge Agneta Lönn and Caroline Lidén for collection of data, and the Regional Oncological Center in Stockholm for access to the Breast Cancer Registry.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria E. C. Sandberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sandberg, M.E.C., Hartman, M., Edgren, G. et al. Diagnostic work-up of contralateral breast cancers has not improved over calendar period. Breast Cancer Res Treat 122, 889–895 (2010). https://doi.org/10.1007/s10549-010-0748-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-0748-8

Keywords

Navigation